(Journal Article): Intensive blood-glucose control with sulphonylureas or insulin compared with convention treatment and risk of complication in patients with type 2 diabetes (UKPDS 33).
United Kingdom Prospective Diabetes Study Group
IN:
Lancet
1998; 352:837-853
Impact Factor(s) of Lancet: 23.407 (2005), 21.713 (2004), 18.316 (2003), 15.397 (2002), 13.251 (2001)